BACKGROUND: Results from HIV vaccine trials on potential volunteers will contribute to global efforts to develop an HIV vaccine. The purpose of this study among police officers in Dar es Salaam, Tanzania, was to explore the underlying reasons that induce people to enrol in an HIV vaccine trial. METHODS: We conducted discussions with eight focus groups, containing a total of 66 police officers. The information collected was analyzed using interpretive description. RESULTS: The results showed that participants were motivated to participate in the trial by altruism, and that the participants experienced some concerns about their participation. They stated that altruism in the fight against HIV infection was the main reason for enrolling in the trial. However, young participants were seriously concerned about a possible loss of close relationships if they enrolled in the HIV vaccine trial. Both men and women feared the effect of the trial on their reproductive biology, and they feared interference with pregnancy norms. They were unsure about risks such as the risks of acquiring HIV infection and of suffering physical harm, and they were unsure of the intentions of the researchers conducting the trial. Further, enrolling in the trial required medical examination, and this led some participants to fear that unknown diseases would be revealed. Other participants, however, saw an opportunity to obtain free health services. CONCLUSIONS: We have shown that specific fears are important concerns when recruiting volunteers to an HIV vaccine trial. More knowledge is needed to determine participants' views and to ensure that they understand the conduct of the trial and the reasons it is being carried out.
BACKGROUND: Results from HIV vaccine trials on potential volunteers will contribute to global efforts to develop an HIV vaccine. The purpose of this study among police officers in Dar es Salaam, Tanzania, was to explore the underlying reasons that induce people to enrol in an HIV vaccine trial. METHODS: We conducted discussions with eight focus groups, containing a total of 66 police officers. The information collected was analyzed using interpretive description. RESULTS: The results showed that participants were motivated to participate in the trial by altruism, and that the participants experienced some concerns about their participation. They stated that altruism in the fight against HIV infection was the main reason for enrolling in the trial. However, young participants were seriously concerned about a possible loss of close relationships if they enrolled in the HIV vaccine trial. Both men and women feared the effect of the trial on their reproductive biology, and they feared interference with pregnancy norms. They were unsure about risks such as the risks of acquiring HIV infection and of suffering physical harm, and they were unsure of the intentions of the researchers conducting the trial. Further, enrolling in the trial required medical examination, and this led some participants to fear that unknown diseases would be revealed. Other participants, however, saw an opportunity to obtain free health services. CONCLUSIONS: We have shown that specific fears are important concerns when recruiting volunteers to an HIV vaccine trial. More knowledge is needed to determine participants' views and to ensure that they understand the conduct of the trial and the reasons it is being carried out.
Authors: Roy D Mugerwa; Pontiano Kaleebu; Peter Mugyenyi; Edward Katongole-Mbidde; David L Hom; Rose Byaruhanga; Robert A Salata; Jerrold J Ellner Journal: BMJ Date: 2002-01-26
Authors: Carey Farquhar; Grace C John-Stewart; Francis N John; Marjory N Kabura; James N Kiarie Journal: AIDS Res Hum Retroviruses Date: 2006-06 Impact factor: 2.205
Authors: Jacqueline M O'Connell; Robert S Hogg; Keith Chan; Steffanie A Strathdee; Nancy McLean; Steve L Martindale; Brian Willoughby; Robert Remis Journal: J Acquir Immune Defic Syndr Date: 2002-12-15 Impact factor: 3.731
Authors: Paul Van de Ven; Limin Mao; June Crawford; Garrett Prestage; Andrew Grulich; John Kaldor; Susan Kippax Journal: Int J STD AIDS Date: 2005-04 Impact factor: 1.359
Authors: R P Strauss; S Sengupta; S Kegeles; E McLellan; D Metzger; S Eyre; F Khanani; C B Emrick; K M MacQueen Journal: J Acquir Immune Defic Syndr Date: 2001-01-01 Impact factor: 3.731
Authors: Chuen-Yen Lau; Edith M Swann; Sagri Singh; Zuhayr Kafaar; Helen I Meissner; James P Stansbury Journal: Vaccine Date: 2011-08-05 Impact factor: 3.641
Authors: Edith A M Tarimo; Joel M Francis; Deodatus Kakoko; Patricia Munseri; Muhammad Bakari; Eric Sandstrom Journal: BMC Public Health Date: 2012-07-19 Impact factor: 3.295
Authors: Edith A M Tarimo; Anna Thorson; Thecla W Kohi; Muhammad Bakari; Fred Mhalu; Asli Kulane Journal: PLoS One Date: 2011-02-16 Impact factor: 3.240
Authors: Edith A M Tarimo; Anna Thorson; Thecla W Kohi; Muhammad Bakari; Eric Sandstrom; Fred Mhalu; Asli Kulane Journal: BMC Infect Dis Date: 2011-10-24 Impact factor: 3.090
Authors: Edith A M Tarimo; Patricia Munseri; Said Aboud; Muhammad Bakari; Fred Mhalu; Eric Sandstrom Journal: PLoS One Date: 2014-03-06 Impact factor: 3.240
Authors: E A M Tarimo; M Bakari; D C V Kakoko; T W Kohi; F Mhalu; E Sandstrom; A Kulane Journal: BMC Public Health Date: 2016-02-24 Impact factor: 3.295
Authors: Edith A M Tarimo; Deodatus C V Kakoko; Thecla W Kohi; Muhammad Bakari; Eric Sandstrom; David Siyame; Fred Mhalu; Asli Kulane Journal: BMC Public Health Date: 2018-07-21 Impact factor: 3.295